{
  "schema_version": "0.1.0",
  "case_id": "HR-ET022",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ET022",
    "display_name": "Ida B. Wells",
    "aliases": [
      "Ida B. Wells-Barnett"
    ],
    "sex": "female",
    "era": "Early 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1862-07-16",
          "display": "July 16, 1862",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1862",
              "display": "1862",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the National Park Service and the Tennessee Encyclopedia."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1931-03-25",
          "display": "March 25, 1931",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1931-03-15",
              "display": "March 15, 1931",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0002"
            ],
            "resolution_status": "conflicting",
            "note": "Given by the National Women's History Museum; the National Park Service, the Tennessee Encyclopedia and Women in World History give March 25."
          },
          {
            "date": {
              "iso": "1931-03-21",
              "display": "March 21, 1931",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "conflicting",
            "note": "Given by the University of Chicago Library finding aid; the other sources give March 25."
          },
          {
            "date": {
              "iso": "1931",
              "display": "1931",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ET022-SYN",
      "ssn": "000-22-5903",
      "date_of_birth": "1957-07-16",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Cordelia Ashworth-Banks, MD",
      "fictional_consultant": {
        "name": "Emeka Lindqvist-Moore, MD",
        "specialty": "Nephrology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1862-07-16",
        "display": "July 16, 1862",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born enslaved in Holly Springs, Mississippi.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1878",
        "display": "autumn 1878",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Both parents and an infant brother died in the yellow fever epidemic; at 16 she took charge of her siblings.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1895",
        "display": "1895",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "A Red Record published.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1895-06-27",
        "display": "June 27, 1895",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Married Ferdinand L. Barnett in Chicago.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1909",
        "display": "1909",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Signed the call for the conference that led to the NAACP.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1927",
        "display": "1927",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Began writing her autobiography.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1930",
        "display": "1930",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Ran for the Illinois State Senate.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1931-03-25",
        "display": "March 25, 1931",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Chicago after a brief illness, of kidney disease (uremia), at 68.",
      "claim_ids": [
        "CLM-0008",
        "CLM-0009"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Ida B. Wells was born enslaved on July 16, 1862, in Holly Springs, Mississippi, during the Civil War.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "context",
          "locator": "roster birth year 1862"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "In the yellow fever epidemic of 1878, when she was 16, both her parents and an infant brother died; she left school and took on the care of her surviving younger siblings, teaching to support them.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the family history and the early loss and responsibility in her social history. The causes of death are as the sources give them.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "lost both parents and one of her siblings at 16"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "parents died in the 1878 epidemic when she was 16"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "her parents and an infant brother died of yellow fever in September 1878"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "began teaching at 16 after both parents died of yellow fever in 1878"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "She was an investigative journalist and editor who documented lynching in the United States, notably in A Red Record (1895), and campaigned against it for the rest of her life; she was also a suffragist and civil rights leader.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her occupation and her habit of checking every figure for herself in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "On June 27, 1895, she married the Chicago attorney Ferdinand L. Barnett, kept her own name alongside his, and settled in Chicago; they had four children.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "married June 27, 1895"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "four children; kept her maiden name"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "She signed the call for the 1909 conference that led to the National Association for the Advancement of Colored People and is considered one of its founders, though she was left off the list of its founding committee and later drew away from it.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "excluded from the Founding Forty"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In 1930 she ran, unsuccessfully, for the Illinois State Senate.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her continued public work in the year before the modern episode's true-frame dates.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "She began writing her autobiography in her last years; it was published after her death as Crusade for Justice: The Autobiography of Ida B. Wells, edited by her youngest daughter, Alfreda M. Duster.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the memoir she is writing in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "began in 1927"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Alfreda M. Duster"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "She died in Chicago on March 25, 1931, at 68, after a brief illness; the cause is given as kidney disease or uremia (uremic poisoning).",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode. The anchor for the modern kidney episode: uremia means kidney failure. Sources differ on the day of death (see the editorial resolutions).",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "after a brief illness, March 25, 1931 (gives her age as sixty-nine)"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died of kidney disease on March 25, 1931 in Chicago"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "died of uremia in Chicago, Illinois, on March 25, 1931"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "context",
          "locator": "gives March 15, 1931, from kidney disease"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "context",
          "locator": "gives March 21, 1931"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "Whether she had chronic kidney disease before her final illness, and what caused her kidney failure, is not recorded in any source consulted; a short final illness ending in uremia is compatible with acute kidney failure, with chronic kidney disease made worse by an acute illness, or with long-standing kidney disease that had not been recognized.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation only. The chronic kidney disease, high blood pressure and every finding in the modern episode are synthetic; the modern episode shows kidney disease found in time, not a claim about her real kidneys.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "derived_from",
          "locator": "kidney disease"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "derived_from",
          "locator": "uremic poisoning"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "derived_from",
          "locator": "a brief illness"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Ida B. Wells",
      "publisher": "National Park Service",
      "url": "https://www.nps.gov/people/idabwells.htm",
      "source_type": "government",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Federal agency biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Ida B. Wells-Barnett (biography)",
      "publisher": "National Women's History Museum",
      "url": "https://www.womenshistory.org/education-resources/biographies/ida-b-wells-barnett",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Museum biography; facts used with citation. Gives the death date as March 15, 1931, which conflicts with the other sources."
    },
    {
      "source_id": "SRC-0003",
      "title": "Wells-Barnett, Ida (1862-1931), Women in World History: A Biographical Encyclopedia",
      "publisher": "Encyclopedia.com (Gale)",
      "url": "https://encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/wells-barnett-ida-1862-1931",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Reference encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "DeCosta-Willis M. Wells-Barnett, Ida B.",
      "publisher": "Tennessee Encyclopedia (Tennessee Historical Society)",
      "url": "https://tennesseeencyclopedia.net/entries/ida-b-wells-barnett/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Historical society encyclopedia entry; facts used with citation. Gives her age at death as sixty-nine."
    },
    {
      "source_id": "SRC-0005",
      "title": "Guide to the Ida B. Wells Papers 1884-1976 (biographical note)",
      "publisher": "University of Chicago Library, Hanna Holborn Gray Special Collections Research Center",
      "url": "https://www.lib.uchicago.edu/e/scrc/findingaids/view.php?eadid=ICU.SPCL.IBWELLS",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Archival finding aid; facts used with citation. Gives the death date as March 21, 1931."
    },
    {
      "source_id": "SRC-0006",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-01-05",
    "index_age": 68,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Chronic kidney disease found in time in a 68-year-old Black woman, a journalist and civic leader in Chicago, who comes in tired with swollen ankles. The teaching contrast is her documented death from kidney failure after a brief illness: here the disease is found, staged and treated years before kidney failure. The episode covers the race-free CKD-EPI 2021 equations (creatinine, then creatinine with cystatin C) and the history of race-based eGFR delaying the recognition and referral of Black patients, as the NKF-ASN Task Force described; staging on the KDIGO 2024 heat map with the urine albumin-to-creatinine ratio and the kidney failure risk equation; finding the cause (home blood pressure, diabetes screening, urinalysis, kidney ultrasound, and a monoclonal protein screen); APOL1 genetic testing offered with counseling and left to her choice; an ARB and an SGLT2 inhibitor with potassium and creatinine checks; blood pressure control; a statin; stopping naproxen; anemia and mineral and bone checks; vaccinations; a nephrology consultation; and shared decisions about kidney replacement options should the disease progress, under the KDIGO 2024 guideline, the 2025 AHA/ACC blood pressure guideline and the CMID chronic kidney disease monograph.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-01-05",
        "purpose": "New patient visit for tiredness and ankle swelling, with kidney function, urine albumin, blood count, and mineral and bone tests"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-01-20",
        "purpose": "Two-week review of home blood pressure readings, the repeat urine test and the kidney ultrasound, with the nephrology consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-02-03",
        "purpose": "Two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-02-17",
        "purpose": "Subsequent annual wellness visit, with advance care planning about kidney treatment options"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-03-03",
        "purpose": "Four weeks after starting dapagliflozin: potassium, creatinine and blood pressure, the losartan dose, and the plan for the months ahead"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be established",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R94.4",
            "display": "Abnormal results of kidney function studies",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-01-20"
      },
      {
        "id": "PRB-002",
        "display": "Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirm",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R03.0",
            "display": "Elevated blood-pressure reading, without diagnosis of hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-01-20"
      },
      {
        "id": "PRB-003",
        "display": "Hypertension, stage 2, confirmed by home readings (average 150/88 mmHg), with chronic kidney disease",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I12.9",
            "display": "Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; no blood pressure from her life is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-01-20"
      },
      {
        "id": "PRB-004",
        "display": "Chronic kidney disease G3b A2 (eGFR 38 by creatinine and cystatin C, urine albumin-to-creatinine ratio 240 and 228 mg/g), present at least two years; small, echogenic kidneys without obstruction; most likely hypertensive kidney disease, with APOL1-associated disease possible; 5-year kidney failure risk about 7%",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N18.32",
            "display": "Chronic kidney disease, stage 3b",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis linked to the kidney disease recorded at her death.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-01-20"
      },
      {
        "id": "PRB-005",
        "display": "Anemia of chronic kidney disease, mild (hemoglobin 11.2 g/dL) with adequate iron stores; a likely part of her tiredness",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D63.1",
            "display": "Anemia in chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-01-20"
      },
      {
        "id": "PRB-006",
        "display": "Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL) with a mildly raised PTH (84 pg/mL); calcium and phosphate normal",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E55.9",
            "display": "Vitamin D deficiency, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory finding, part of the mineral and bone check in kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-01-20"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxen",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One or two tablets up to three times a day as needed"
        },
        "start_date": "2026-01-05",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic switch from over-the-counter naproxen, a nephrotoxin, to acetaminophen.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Losartan 50 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979492",
            "display": "losartan potassium 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-01-20",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ARB for hypertensive kidney disease with albuminuria, started on the consultant's advice.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "end_date": "2026-03-03"
      },
      {
        "id": "MED-003",
        "display": "Atorvastatin 20 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617310",
            "display": "atorvastatin 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-01-20",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic statin for an adult 50 or older with eGFR below 60, as KDIGO advises.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-01-20",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D replacement for deficiency with a mildly raised PTH.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Dapagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1488569",
            "display": "dapagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-02-03",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic SGLT2 inhibitor for chronic kidney disease with albuminuria of 200 mg/g or more, without diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Losartan 100 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979480",
            "display": "losartan potassium 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-03-03",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase to the maximum tolerated ARB dose for albuminuria, as the consultant advised.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V1",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 22,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29,
          "text": "Keep at 22 or above in kidney disease"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-BUN-V1",
        "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
        "label": "Urea nitrogen",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 28,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8,
          "high": 23
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3094-0",
            "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 1.42,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic creatinine; raised. Two years ago an outside laboratory reported 1.05 mg/dL (note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR, creatinine (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 40,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic eGFR from creatinine by the race-free CKD-EPI 2021 equation; G3b.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CYSC-V1",
        "display": "Cystatin C [Mass/volume] in Serum or Plasma",
        "label": "Cystatin C",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 1.68,
        "unit": "mg/L",
        "reference_range": {
          "low": 0.53,
          "high": 0.95
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33863-2",
            "display": "Cystatin C [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cystatin C, drawn with the creatinine to confirm the estimate.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFRCC-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR, creatinine and cystatin C (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 38,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "The confirmatory estimate KDIGO prefers when decisions depend on accuracy; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98980-6",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic confirmatory eGFR from creatinine and cystatin C (CKD-EPI 2021, race-free); G3b.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 240,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; moderately increased (A2), to be repeated.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 5.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 6.5% or higher is diabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c; no diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 11.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5,
          "text": "Anemia in women is below 12.0 g/dL"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 168,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 300
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ferritin; iron stores adequate.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSAT-V1",
        "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
        "label": "Transferrin saturation",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 24,
        "unit": "%",
        "reference_range": {
          "low": 20,
          "high": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2502-3",
            "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic transferrin saturation; adequate.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 9.2,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic calcium; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHOS-V1",
        "display": "Phosphate [Mass/volume] in Serum or Plasma",
        "label": "Phosphate",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 3.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 2.5,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2777-1",
            "display": "Phosphate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic phosphate; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PTH-V1",
        "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
        "label": "Parathyroid hormone, intact",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 84,
        "unit": "pg/mL",
        "reference_range": {
          "low": 15,
          "high": 65
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2731-8",
            "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intact PTH; mildly raised.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V1",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 17,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100,
          "text": "Below 20 ng/mL deficient; 20 to 29 insufficient"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D; deficient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 214,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel, once at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 136,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel, once at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 52,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel, once at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel, once at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH for fatigue; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-01-05",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen for fatigue; minimal symptoms. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V2",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 228,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat urine albumin-to-creatinine ratio, confirming moderately increased albuminuria.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 4.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V3",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 22,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29,
          "text": "Keep at 22 or above in kidney disease"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-BUN-V3",
        "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
        "label": "Urea nitrogen",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 30,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8,
          "high": 23
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3094-0",
            "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 1.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic creatinine two weeks after starting losartan; a rise of about 6%, expected.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR, creatinine (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-03",
        "value": 38,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; a small expected dip.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after starting dapagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after starting dapagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V5",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 23,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29,
          "text": "Keep at 22 or above in kidney disease"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after starting dapagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-BUN-V5",
        "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
        "label": "Urea nitrogen",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 31,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8,
          "high": 23
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3094-0",
            "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after starting dapagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 1.56,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic creatinine four weeks after starting dapagliflozin; about 10% above the first value, within the expected range.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR, creatinine (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-03",
        "value": 36,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; the expected small dip after an SGLT2 inhibitor.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V4",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-02-17",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic annual depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-MINICOG-V4",
        "display": "Total score [Mini-Cog]",
        "label": "Mini-Cog",
        "status": "final",
        "effective_date": "2026-02-17",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72233-0",
            "display": "Total score [Mini-Cog]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cognitive screen at the annual wellness visit (recall 3 of 3, clock normal).",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V4",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-17",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; low risk.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-01-05",
          "end": "2026-01-05"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline ECG for high blood pressure and kidney disease; sinus rhythm with voltage criteria for left ventricular hypertrophy (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Ultrasound of both kidneys and the bladder",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1334074007",
            "display": "Ultrasonography of bilateral kidneys and bladder",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-01-20",
          "end": "2026-01-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ultrasound: right kidney 9.6 cm and left 9.4 cm, both with increased echogenicity and thinned cortex, no hydronephrosis, stones or masses; bladder normal (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Kidney diet session with the dietitian: sodium below 2 g a day, protein about 0.8 g per kg, plant-rich meals, no potassium restriction at present",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "410177006",
            "display": "Special diet education",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-02-03",
          "end": "2026-02-03"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medical nutrition therapy for chronic kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Advance care planning conversation, about 25 minutes, including kidney treatment options",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-02-17",
          "end": "2026-02-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences in the modern episode.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "High-dose influenza vaccine, this season",
        "status": "completed",
        "date": "2026-01-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "135",
            "display": "Influenza, high-dose, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination; none yet this season.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-01-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose; no pneumococcal vaccine on record.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-01-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for chronic kidney disease; surface antibody negative.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-02-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose, four weeks after the first; series complete.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Respiratory syncytial virus vaccine, adjuvanted (RSVPreF3), single dose",
        "status": "completed",
        "date": "2026-02-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "303",
            "display": "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single RSV dose for an adult under 75 with chronic kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-02-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose; no zoster vaccine on record.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "COVID-19 vaccine, mRNA, this season",
        "status": "completed",
        "date": "2026-03-03",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination, spaced from the other vaccines at her request.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "Died in the yellow fever epidemic when she was 16",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "FH-002",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Died in the yellow fever epidemic when she was 16",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "FH-003",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "BRO",
          "display": "brother"
        },
        "condition": "An infant brother died in the same yellow fever epidemic",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient visit for tiredness and ankle swelling, with kidney function, urine albumin, blood count, and mineral and bone tests",
        "status": "finished",
        "date": "2026-01-05",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review of home blood pressure readings, the repeat urine test and the kidney ultrasound, with the nephrology consultation",
        "status": "finished",
        "date": "2026-01-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Two-week review of home blood pressure readings, the repeat urine test and the kidney ultrasound, with the nephrology consultation",
          "hpi": {
            "narrative": "Mrs. Wells returns two weeks after her first visit with her home blood pressure log and the outside report she obtained: two years ago another clinic measured her creatinine at 1.05 mg/dL and reported an eGFR of 64 as normal. That report used an older equation that raised the estimate for Black patients; recalculated with the race-free CKD-EPI 2021 equation it is 59, already reduced, and no urine albumin test was done then. Her home readings over seven days average 150/88. She stopped naproxen at the first visit and uses acetaminophen for her knees, which works. Her ankles still swell a little by evening and she is still tired in the afternoons. She had her kidney ultrasound this morning and saw Dr. Lindqvist-Moore of nephrology afterwards. She asked to see each calculation and was given copies.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 150/88 over seven days"
              },
              {
                "label": "Earlier result",
                "value": "Creatinine 1.05 two years ago, reported with a race-adjusted eGFR of 64; race-free eGFR 59"
              },
              {
                "label": "Naproxen",
                "value": "Stopped; acetaminophen instead"
              },
              {
                "label": "Symptoms",
                "value": "Tiredness and evening ankle swelling, unchanged"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired in the afternoons; no fever or weight loss"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Mild ankle swelling by evening; no chest pain or breathlessness lying flat"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No blood in the urine, foamy urine, or burning"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Knee aching, controlled with acetaminophen"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 154/90 (average of two), pulse 76; weight 70.0 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur or rub; trace ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Confirmed and staged. Race-free eGFR 40 by creatinine and 38 by creatinine with cystatin C, with the earlier value of 59 two years ago showing the disease has been present for at least that long and has fallen by about 10 a year, which is rapid. The older race-adjusted equation would read today's creatinine as 44 and the earlier one as a normal 64; the race-free result recognizes her disease earlier, as the NKF-ASN Task Force intended. Urine albumin-to-creatinine ratio 228 mg/g on repeat (240 at intake): A2. Urinalysis from the first visit: 1+ protein, no blood, bland sediment. No monoclonal protein; free light chain ratio normal. Hepatitis B surface antigen, hepatitis C antibody and HIV negative; hepatitis B surface antibody negative. Ultrasound today: kidneys 9.6 and 9.4 cm, both echogenic with thin cortex, no obstruction or stones. Kidney failure risk about 7% at 5 years and 2% at 2 years. Dr. Lindqvist-Moore judges hypertensive kidney disease most likely, with APOL1-associated disease possible",
              "plan": [
                "Losartan 50 mg daily; potassium and creatinine in two weeks",
                "Dapagliflozin to follow once potassium and creatinine are stable",
                "Kidney education session and a dietitian session",
                "APOL1 testing offered after counseling; she chose to defer it"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Home average 150/88 with clinic 154/90: stage 2 hypertension confirmed. Intake ECG showed left ventricular hypertrophy by voltage, consistent with longstanding high blood pressure",
              "plan": [
                "Losartan as above; goal below 130/80, and a systolic below 120 if tolerated",
                "Home readings the week before each visit"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Anemia of chronic kidney disease",
              "assessment": "Hemoglobin 11.2 g/dL with ferritin 168 ng/mL and transferrin saturation 24%: iron replete; mild anemia from kidney disease, likely part of her tiredness. No treatment needed at this level",
              "plan": [
                "Hemoglobin again in three months"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Vitamin D deficiency with a mildly raised PTH",
              "assessment": "25-hydroxyvitamin D 17 ng/mL and PTH 84 pg/mL, with normal calcium and phosphate: correct the vitamin D first",
              "plan": [
                "Vitamin D3 1,000 units daily; PTH and vitamin D in three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "154/90",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Seven days to confirm; then the week before each visit while medicines change",
              "status": "completed_today",
              "detail": "Seven-day average 150/88 confirms hypertension",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; three to six months after a treatment change; then about twice a year at G3b A2",
              "status": "completed_today",
              "detail": "228 mg/g, confirming the intake result of 240 (A2)",
              "observation_ids": [
                "OBS-UACR-V2"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine with cystatin C (eGFRcr-cys)",
              "cadence": "When decisions depend on accuracy, as at diagnosis and referral",
              "status": "up_to_date",
              "detail": "Done at intake: eGFR 40 by creatinine, 38 with cystatin C; both race-free",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-NKF-ASN-2021",
                "GL-CKDEPI-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urinalysis with microscopy",
              "cadence": "At diagnosis and with any change",
              "status": "up_to_date",
              "detail": "Intake sample: 1+ protein, no blood, bland sediment",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Kidney ultrasound",
              "cadence": "Once, at diagnosis of chronic kidney disease of uncertain cause",
              "status": "completed_today",
              "detail": "Small echogenic kidneys; no obstruction or stones",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Monoclonal protein screen and hepatitis B, hepatitis C and HIV tests",
              "cadence": "Once, for chronic kidney disease of uncertain cause in an older adult",
              "status": "up_to_date",
              "detail": "Drawn at intake: no monoclonal protein, normal free light chain ratio; hepatitis B surface antigen, hepatitis C antibody and HIV negative; not immune to hepatitis B",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Kidney failure risk equation, 2- and 5-year",
              "cadence": "At diagnosis and yearly at G3 to G5; before referral decisions",
              "status": "completed_today",
              "detail": "About 7% at 5 years and 2% at 2 years (eGFR 38, albumin-to-creatinine ratio 240 mg/g, age 68, female)",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, sodium, bicarbonate, urea nitrogen, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ARB or SGLT2 inhibitor; then with each eGFR check (about twice a year at G3b A2)",
              "status": "ordered",
              "detail": "Losartan started today; check in two weeks",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "At least yearly at G3; recheck in three months when mildly low",
              "status": "up_to_date",
              "detail": "11.2 g/dL at intake; iron studies adequate",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate, intact PTH and 25-hydroxyvitamin D",
              "cadence": "Baseline at G3; then every 6 to 12 months; vitamin D and PTH three months after starting replacement",
              "status": "up_to_date",
              "detail": "At intake: calcium 9.2, phosphate 3.8 mg/dL; PTH 84 pg/mL; vitamin D 17 ng/mL; vitamin D3 started today",
              "guideline_ids": [
                "GL-KDIGO-MBD-2017",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Once at diagnosis; statin for adults 50 or older with eGFR below 60 without routine repeat testing",
              "status": "up_to_date",
              "detail": "LDL 136 mg/dL at intake; atorvastatin 20 mg started today, without a routine repeat",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication review: NSAIDs, contrast, dose adjustment, sick-day rules",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Naproxen stopped and acetaminophen used instead; sick-day rules for losartan explained in writing",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, plant-rich diet",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Dietitian session booked; sodium and protein targets discussed",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccines for kidney disease (influenza, pneumococcal, hepatitis B, COVID-19)",
              "cadence": "Review yearly; hepatitis B series if not immune",
              "status": "completed_today",
              "detail": "High-dose influenza, PCV20 and hepatitis B dose 1 given after she agreed",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Nephrology",
              "cadence": "When 5-year kidney failure risk is 3 to 5% or more, eGFR falls quickly, or the cause is unclear",
              "status": "completed_today",
              "detail": "Seen by Dr. Lindqvist-Moore today; review in three months",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Potassium and creatinine in two weeks. Kidney education session and dietitian session in the next month. Call for dizziness, swelling of the lips or tongue (call 911), or vomiting or diarrhea that stops her eating and drinking (hold losartan that day)",
          "guideline_ids": [
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-KDIGO-MBD-2017",
            "GL-AHA-HTN-2025",
            "GL-NKF-ASN-2021",
            "GL-CKDEPI-2021",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin",
        "status": "finished",
        "date": "2026-02-03",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin",
          "hpi": {
            "narrative": "Mrs. Wells returns two weeks after starting losartan 50 mg, atorvastatin and vitamin D3. She has had no dizziness, cough or swelling of the lips. Her home readings average 140/84. Her ankles swell less. She met the dietitian this morning and is cutting salt, and she has read about SGLT2 inhibitors and asked how much they lower the risk of kidney failure; the trial evidence in people with and without diabetes was explained. She wants to start.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 140/84"
              },
              {
                "label": "Side effects",
                "value": "None"
              },
              {
                "label": "Diet",
                "value": "Dietitian session this morning"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Still tired in the afternoons, a little less"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "Less ankle swelling; no chest pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness on standing"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 142/84, pulse 74; weight 69.6 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling today"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Potassium 4.9 mmol/L and creatinine 1.50 mg/dL (eGFR 38, from 40): the expected small rise on losartan, well under 30%. Safe to add an SGLT2 inhibitor, which KDIGO recommends with albuminuria of 200 mg/g or more",
              "plan": [
                "Dapagliflozin 10 mg daily, with sick-day rules",
                "Potassium and creatinine in four weeks",
                "No potassium restriction at present"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Improving, not at goal; dapagliflozin will lower it slightly; losartan to be increased once kidney function is stable on both",
              "plan": [
                "Home readings the week before the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "142/84",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Seven days to confirm; then the week before each visit while medicines change",
              "status": "completed_today",
              "detail": "Average 140/84",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, sodium, bicarbonate, urea nitrogen, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ARB or SGLT2 inhibitor; then with each eGFR check (about twice a year at G3b A2)",
              "status": "completed_today",
              "detail": "Two weeks after losartan: sodium 138, potassium 4.9, bicarbonate 22 mmol/L; urea nitrogen 30, creatinine 1.50 mg/dL; eGFR 38",
              "observation_ids": [
                "OBS-NA-V3",
                "OBS-K-V3",
                "OBS-CO2-V3",
                "OBS-BUN-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; three to six months after a treatment change; then about twice a year at G3b A2",
              "status": "up_to_date",
              "detail": "228 mg/g two weeks ago; next three months after treatment began",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication review: NSAIDs, contrast, dose adjustment, sick-day rules",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No NSAIDs; acetaminophen within limits; sick-day rules for dapagliflozin added",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety: dizziness, genital infection, urine volume, sick-day rules",
              "cadence": "After starting an SGLT2 inhibitor",
              "status": "completed_today",
              "detail": "Expected rise in urine volume and a small eGFR dip explained; genital hygiene advice; hold on sick days and before procedures",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, plant-rich diet",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Dietitian session today: sodium below 2 g, protein about 0.8 g per kg, plant-rich meals",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "At least yearly at G3; recheck in three months when mildly low",
              "status": "up_to_date",
              "detail": "11.2 g/dL at intake; recheck in three months",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate, intact PTH and 25-hydroxyvitamin D",
              "cadence": "Baseline at G3; then every 6 to 12 months; vitamin D and PTH three months after starting replacement",
              "status": "up_to_date",
              "detail": "Vitamin D3 started two weeks ago; recheck in three months",
              "guideline_ids": [
                "GL-KDIGO-MBD-2017"
              ]
            }
          ],
          "follow_up": "Annual wellness visit in two weeks. Potassium and creatinine in four weeks. Call for dizziness, fainting, vomiting or diarrhea (hold dapagliflozin and losartan that day), or genital itching",
          "guideline_ids": [
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-AHA-HTN-2025",
            "GL-KDIGO-MBD-2017",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Subsequent annual wellness visit",
        "status": "finished",
        "date": "2026-02-17",
        "visit_type": "annual_wellness_subsequent",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "281038008",
          "display": "Geriatric annual health check",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Subsequent annual wellness visit",
          "billing_note": "HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by her on paper before the visit and reviewed with her by Dr. Ashworth-Banks",
          "hpi": {
            "narrative": "Mrs. Wells comes for her subsequent annual wellness visit two weeks after starting dapagliflozin and four weeks after starting losartan for chronic kidney disease G3b A2 with hypertension. She has had no dizziness, faintness or genital itching and passes a little more urine than before. Her home blood pressure readings average 134/80. Her ankles no longer swell by evening, and she is less tired in the afternoons. Acetaminophen controls her knee aching and she has taken no naproxen since the first visit. Last week she went to the kidney education session at the health center, brought a page of questions, and asked to spend part of today on what the treatment options would mean for her if her kidneys failed one day. She has had no falls, emergency visits or hospital stays in the past year.",
            "elements": [
              {
                "label": "Visit",
                "value": "Subsequent annual wellness visit, age 68"
              },
              {
                "label": "New medicines",
                "value": "Losartan for four weeks and dapagliflozin for two, without side effects"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 134/80"
              },
              {
                "label": "Symptoms",
                "value": "Ankle swelling gone; less tired"
              },
              {
                "label": "Safety events",
                "value": "No falls, emergency visits or hospital stays"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair; better than a month ago"
            },
            {
              "domain": "Psychosocial",
              "finding": "Lives with her husband; a wide circle of colleagues and readers; busy with writing and civic work; stress from deadlines is manageable"
            },
            {
              "domain": "Behavioral",
              "finding": "Never smoker; under one drink a week; walks most days; cutting salt with help from the dietitian; sleeps about six and a half hours"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in bathing, dressing, eating, toileting and transfers"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Manages her own medicines, money, correspondence and travel"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors working; handrail on the front steps; no loose rugs"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Hears well; reading glasses; last eye examination more than two years ago"
            },
            {
              "domain": "Bladder",
              "finding": "Passes a little more urine since dapagliflozin; no leakage"
            },
            {
              "domain": "Memory",
              "finding": "No concerns"
            },
            {
              "domain": "Health care experiences",
              "finding": "Wants to see the evidence and the numbers; says she was once told a kidney result was normal without anyone explaining how it was calculated"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tiredness in the afternoons, less than before; weight down 1.2 kg since intake"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision with reading glasses"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing difficulty; no mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, poor appetite or blood in the stool"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning, genital itching or blood in the urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Knee aching on stairs, controlled with acetaminophen"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No itching or rash"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness on standing, numbness or memory change"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-2 0"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump or nipple change"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 69.2 kg; blood pressure 136/82 seated and 132/80 standing, without symptoms"
            },
            {
              "system": "Eyes",
              "finding": "Near vision 20/30 with reading glasses; undilated fundi show mild arteriolar narrowing"
            },
            {
              "system": "Ears",
              "finding": "Whispered-voice test passed in both ears"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes; no carotid bruits"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no masses or bruits"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Crepitus in both knees without effusion; Timed Up and Go 11 seconds with a steady gait"
            },
            {
              "system": "Neurological",
              "finding": "Oriented; Mini-Cog 5 of 5 (recall 3 of 3, clock normal)"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged, exact and well informed; judgment intact"
            }
          ],
          "assessment_plan": [
            {
              "display": "Subsequent annual wellness visit completed",
              "assessment": "Health risk assessment reviewed, prevention plan updated and a written copy given. Depression, alcohol, cognitive and fall-risk screens are negative",
              "plan": [
                "Mammogram and bone density scan ordered",
                "Stool immunochemical test kit given",
                "Eye examination with her optometrist, with a dilated view of the retina for hypertensive changes",
                "Next annual wellness visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Tolerating losartan and dapagliflozin; ankle swelling resolved. Potassium and creatinine are due at four weeks on dapagliflozin, at the next visit. She has been taught the options for kidney failure well before any decision is needed",
              "plan": [
                "Potassium and creatinine at the review in two weeks",
                "Continue sick-day rules for losartan and dapagliflozin"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Home average 134/80, not yet below 130/80; no orthostatic drop",
              "plan": [
                "Continue home readings twice a day for the week before the next visit"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Alcohol misuse screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 1"
            },
            {
              "service": "Cognitive assessment",
              "status": "completed_today",
              "detail": "Mini-Cog 5 of 5",
              "guideline_ids": [
                "GL-AWV-CMS"
              ]
            },
            {
              "service": "Falls prevention",
              "status": "completed_today",
              "detail": "No falls; Timed Up and Go 11 seconds; home safety reviewed",
              "guideline_ids": [
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "ordered",
              "detail": "Mammogram every two years to 74; last one more than two years ago",
              "guideline_ids": [
                "GL-USPSTF-BRCA-2024"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Stool immunochemical test, her choice, to avoid bowel preparation fluids and sedation while her kidney medicines are new",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Bone density (DXA)",
              "status": "ordered",
              "detail": "Women 65 and older; none on record; kidney disease adds to fracture risk",
              "guideline_ids": [
                "GL-USPSTF-OSTEO-2025",
                "GL-KDIGO-MBD-2017"
              ]
            },
            {
              "service": "Hepatitis C and HIV screening",
              "status": "up_to_date",
              "detail": "Both negative with the kidney tests last month"
            },
            {
              "service": "Influenza vaccine, this season",
              "status": "up_to_date",
              "detail": "High-dose vaccine last month",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 last month; no further doses",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "Dose 2 of HepB-CpG today; series complete; antibody check after the series because of kidney disease",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "completed_today",
              "detail": "Single dose for an adult under 75 with chronic kidney disease",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "Dose 1 today; dose 2 in two to six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "due",
              "detail": "At the next visit, to space the vaccines at her request",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus booster",
              "status": "up_to_date",
              "detail": "Tdap six years ago"
            },
            {
              "service": "Eye examination",
              "status": "due",
              "detail": "More than two years since the last; dilated examination for hypertensive retinal changes"
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Never smoker"
            },
            {
              "service": "Cervical cancer screening",
              "status": "not_indicated",
              "detail": "Not recommended after 65 with adequate prior screening, which she reports"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 25 minutes, with her consent, building on the kidney education session. She understands that her kidney disease is at stage G3b and that, with treatment, most people at her stage do not reach kidney failure; the estimate of her own 5-year risk was explained as about 7 in 100. If her kidneys were to fail, she would want to be assessed for a transplant, would prefer home dialysis to center dialysis if dialysis were needed, and wants conservative kidney management explained to her again before any choice is made. She wants full treatment for illness that can be reversed. She has named a health care agent, recorded in the confidential part of the chart and not named here. To be revisited yearly, at any sustained fall in eGFR below 20, or after a serious illness.",
          "follow_up": "Review in two weeks with potassium and creatinine. Mammogram, bone density scan and stool test as ordered. Next annual wellness visit in one year",
          "guideline_ids": [
            "GL-AWV-CMS",
            "GL-PREV-2026",
            "GL-USPSTF-BRCA-2024",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-OSTEO-2025",
            "GL-USPSTF-FALLS-2024",
            "GL-CDC-IMZ-2026",
            "GL-KDIGO-CKD-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Medicare annual wellness visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "ENC-005",
        "display": "Four weeks after starting dapagliflozin: potassium, creatinine and blood pressure, the losartan dose, and the plan for the months ahead",
        "status": "finished",
        "date": "2026-03-03",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Four weeks after starting dapagliflozin: potassium, creatinine and blood pressure, the losartan dose, and the plan for the months ahead",
          "hpi": {
            "narrative": "Mrs. Wells returns two weeks after her annual wellness visit and four weeks after starting dapagliflozin. She has had no dizziness, genital itching or sick days. Her home readings average 130/78. Her ankles have not swollen for three weeks and her afternoons are easier, though she still tires on long writing days. Since the kidney education session she has written down her questions about transplant evaluation for her next nephrology visit. She asked for the COVID-19 vaccine today.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 130/78"
              },
              {
                "label": "Side effects",
                "value": "None"
              },
              {
                "label": "Symptoms",
                "value": "No ankle swelling; less tired"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Less tired; tires on long writing days"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 132/80, pulse 72; weight 68.9 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Potassium 4.8 mmol/L; creatinine 1.56 mg/dL, eGFR 36: about 10% below the first value, the expected effect of losartan and dapagliflozin together and well within the 30% that is accepted. On both medicines as planned",
              "plan": [
                "Increase losartan to 100 mg daily, the highest dose, for albuminuria",
                "Potassium and creatinine in two to four weeks",
                "Urine albumin-to-creatinine ratio, hemoglobin, PTH and vitamin D at three months",
                "Nephrology review at three months"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Close to goal: 132/80 in the clinic, 130/78 at home",
              "plan": [
                "Losartan increase as above; home readings the week after the change"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Anemia of chronic kidney disease",
              "assessment": "Tiredness improving; no new bleeding symptoms",
              "plan": [
                "Hemoglobin at three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "132/80",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Seven days to confirm; then the week before each visit while medicines change",
              "status": "completed_today",
              "detail": "Average 130/78",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, sodium, bicarbonate, urea nitrogen, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ARB or SGLT2 inhibitor; then with each eGFR check (about twice a year at G3b A2)",
              "status": "completed_today",
              "detail": "Four weeks after dapagliflozin: sodium 139, potassium 4.8, bicarbonate 23 mmol/L; urea nitrogen 31, creatinine 1.56 mg/dL; eGFR 36. Repeat two to four weeks after today's losartan increase",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CO2-V5",
                "OBS-BUN-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; three to six months after a treatment change; then about twice a year at G3b A2",
              "status": "due",
              "detail": "Three months after treatment began",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication review: NSAIDs, contrast, dose adjustment, sick-day rules",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No NSAIDs; medicines checked for kidney dosing",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety: dizziness, genital infection, urine volume, sick-day rules",
              "cadence": "After starting an SGLT2 inhibitor",
              "status": "completed_today",
              "detail": "No dizziness, genital infection or sick days",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "At least yearly at G3; recheck in three months when mildly low",
              "status": "due",
              "detail": "At three months",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate, intact PTH and 25-hydroxyvitamin D",
              "cadence": "Baseline at G3; then every 6 to 12 months; vitamin D and PTH three months after starting replacement",
              "status": "due",
              "detail": "PTH and vitamin D at three months on vitamin D3",
              "guideline_ids": [
                "GL-KDIGO-MBD-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccines for kidney disease (influenza, pneumococcal, hepatitis B, COVID-19)",
              "cadence": "Review yearly; hepatitis B series if not immune",
              "status": "completed_today",
              "detail": "COVID-19 vaccine today; influenza, PCV20, hepatitis B series, RSV and zoster dose 1 done; zoster dose 2 due in two to six months; hepatitis B antibody check due",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Nephrology",
              "cadence": "When 5-year kidney failure risk is 3 to 5% or more, eGFR falls quickly, or the cause is unclear",
              "status": "due",
              "detail": "Review with Dr. Lindqvist-Moore at three months",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            }
          ],
          "follow_up": "Potassium and creatinine in two to four weeks. Review with the urine albumin, hemoglobin, PTH and vitamin D in three months, and nephrology review then. Call for dizziness, vomiting or diarrhea (hold losartan and dapagliflozin that day), or swelling of the lips or tongue (call 911)",
          "guideline_ids": [
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-AHA-HTN-2025",
            "GL-KDIGO-MBD-2017",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026"
          ]
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-01-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 157,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 70.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 164,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 94,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated automated cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-01-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 157,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 70.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 154,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 90,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated automated cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-02-03",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 157,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 142,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated automated cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-02-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 157,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the annual wellness visit, seated after five minutes' rest, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-03-03",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 157,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated automated cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Lives in Chicago with her husband; a journalist, lecturer and civic leader; ran for the state senate last year; now writing her memoir",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern social history anchored to her documented life; her husband is mentioned only as part of the household.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lost both parents and a baby brother at 16 and raised her younger siblings; says she has been looking after other people since then and has put her own health last",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic statement in the modern episode, anchored to the documented losses.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Tobacco: never. Alcohol: a glass of wine on occasions, under one drink a week. No drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry for the modern episode; her real habits were not researched and are not used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Medicare with a supplemental plan; medicines affordable on her plan",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic insurance status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Wants to see her own results and the evidence behind each recommendation, and to decide for herself; reads her laboratory reports line by line",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic preference in the modern episode, anchored to her documented work as an investigative journalist.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities and instrumental activities of daily living; walks to meetings and the newspaper office, slowed by knee aching and by tiredness this winter",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, precise and questioning; asked for copies of every result; mood steady; PHQ-9 score 4",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "New chronic kidney disease, probably G3b A2, of uncertain cause in a 68-year-old Black woman with tiredness, ankle swelling and high blood pressure readings: race-free eGFR 40 by creatinine and 38 with cystatin C, and a urine albumin-to-creatinine ratio of 240 mg/g. Please advise on the cause and further evaluation, APOL1 genetic testing, kidney-protective treatment and its order, the anemia and mineral findings, and how and when to plan for the future",
        "urgency": "Within two weeks, on the day of her two-week visit, after the repeat urine test and the kidney ultrasound",
        "pertinent_history": "Mrs. Wells is a journalist and civic leader, active and independent, who has been tired for some months and notices ankle swelling by evening. She has taken over-the-counter naproxen for knee aching for about a year; it was stopped today. She has no diabetes symptoms, no known kidney disease, and no blood in the urine. She recalls being told by another clinic two years ago that a kidney test was normal and is obtaining that report. Her parents and an infant brother died in an epidemic in her youth; no family kidney history is known. Blood pressure 164/94 (average of two readings), pulse 78, weight 70.4 kg, BMI 28.6; trace ankle swelling. Results today: sodium 139, potassium 4.6, bicarbonate 22 mmol/L; urea nitrogen 28, creatinine 1.42 mg/dL; eGFR 40 (CKD-EPI 2021 creatinine, race-free); cystatin C 1.68 mg/L, eGFR 38 (creatinine and cystatin C); urine albumin-to-creatinine ratio 240 mg/g; fasting glucose 94 mg/dL and A1c 5.6%; hemoglobin 11.2 g/dL, ferritin 168 ng/mL, transferrin saturation 24%; calcium 9.2, phosphate 3.8 mg/dL; intact PTH 84 pg/mL; 25-hydroxyvitamin D 17 ng/mL; LDL 136 mg/dL; TSH 1.9; PHQ-9 4. ECG: sinus rhythm with voltage criteria for left ventricular hypertrophy. Sent today: urinalysis with microscopy, serum protein electrophoresis with free light chains, hepatitis B, hepatitis C and HIV tests. Planned: a home blood pressure monitor for seven days, a repeat urine albumin test and a kidney ultrasound on the morning of your visit. She asks to see every result and how each was calculated",
        "questions": [
          "What is the most likely cause of her kidney disease, and does she need further tests, including a kidney biopsy?",
          "Do you agree with the race-free staging, and how should we use cystatin C from here?",
          "Should she be offered APOL1 genetic testing, and how would a result change her care?",
          "Which kidney-protective medicines do you advise, in what order, and with what blood pressure target?",
          "How should we manage the mild anemia, the low vitamin D and the raised PTH?",
          "How often should she be seen by nephrology, and when should planning for kidney replacement begin?"
        ]
      },
      "consultant_note": {
        "history": "Mrs. Wells, 68, is seen at the request of Dr. Ashworth-Banks for chronic kidney disease found two weeks ago. She has been tired for some months and has had ankle swelling by evening. She took naproxen for knee aching for about a year and stopped it two weeks ago. She has no diabetes, no visible blood in the urine, no foamy urine, no rash, joint swelling or mouth ulcers, and no history of kidney stones or urinary infections. She brought an outside report from two years ago: creatinine 1.05 mg/dL with an eGFR of 64 reported as normal, from an equation with a race coefficient. Her home blood pressure average over seven days is 150/88. She asked detailed questions and wants the evidence behind each recommendation",
        "data_reviewed": "Intake results as listed by Dr. Ashworth-Banks. Recalculated earlier value: eGFR 59 by the race-free CKD-EPI 2021 equation (64 by the older race-based equation). Today's results by the older equation would read 44. Urine albumin-to-creatinine ratio 228 mg/g today (240 at intake). Urinalysis: 1+ protein, no blood, no casts; bland sediment. Serum protein electrophoresis: no monoclonal protein; free light chain ratio 1.2, normal for her eGFR. Hepatitis B surface antigen, hepatitis C antibody and HIV negative; hepatitis B surface antibody negative. Kidney ultrasound this morning: right kidney 9.6 cm, left 9.4 cm, both echogenic with thinned cortex, no hydronephrosis, stones or masses. ECG with voltage criteria for left ventricular hypertrophy. Kidney failure risk equation: about 7% at 5 years, 2% at 2 years",
        "exam": [
          {
            "system": "Vital signs",
            "finding": "Blood pressure 154/90 and pulse 76, measured in clinic today"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; no rub; trace ankle swelling"
          },
          {
            "system": "Skin and joints",
            "finding": "No rash; no joint swelling"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Chronic kidney disease G3b A2",
            "assessment": "Chronic kidney disease G3b A2, present for at least two years and falling by about 10 mL/min a year. The bland urine, moderate albuminuria, small echogenic kidneys and left ventricular hypertrophy point to hypertensive kidney disease; APOL1-associated kidney disease is possible in a woman of African ancestry with this picture. There is no sign of diabetic, glomerular inflammatory or monoclonal disease, and naproxen may have added to the decline. A biopsy is not indicated now; it would be if blood appeared in the urine, albuminuria rose toward the nephrotic range, or eGFR fell quickly despite treatment. The race-free staging is correct: the older equation would have read the earlier result as normal and delayed recognition, which is the harm the NKF-ASN Task Force recommendation was written to end. Use creatinine for routine monitoring and add cystatin C when a decision depends on accuracy, such as drug dosing or transplant evaluation"
          },
          {
            "problem_id": "PRB-003",
            "display": "Hypertension with chronic kidney disease",
            "assessment": "Stage 2 hypertension, confirmed at home, with target organ damage. An ARB is the foundation with this albuminuria. Goal below 130/80, and a systolic below 120 by standardized measurement if she tolerates it without dizziness"
          },
          {
            "problem_id": "PRB-005",
            "display": "Anemia of chronic kidney disease",
            "assessment": "Mild and iron replete; no erythropoiesis-stimulating agent is indicated. Recheck in three months"
          },
          {
            "problem_id": "PRB-006",
            "display": "Vitamin D deficiency with a mildly raised PTH",
            "assessment": "Correct the vitamin D deficiency first; the PTH may settle. No calcitriol or phosphate binder"
          }
        ],
        "recommendations": [
          "Losartan 50 mg daily now, with potassium and creatinine in two weeks; accept a creatinine rise of up to 30%",
          "Then dapagliflozin 10 mg daily, which KDIGO recommends at her eGFR with albuminuria of 200 mg/g or more, with a further check at two to four weeks; then increase losartan to 100 mg if potassium stays below 5.5 mmol/L. Finerenone is not indicated without diabetes",
          "Sick-day rules in writing: hold losartan and dapagliflozin on days of vomiting, diarrhea or not eating, and before surgery or contrast",
          "No NSAIDs; acetaminophen for knee pain",
          "Atorvastatin 20 mg daily, as KDIGO advises for adults 50 or older with eGFR below 60",
          "Vitamin D3 1,000 units daily; PTH, vitamin D and hemoglobin in three months",
          "Hepatitis B vaccination, since she is not immune, with the other vaccines her primary clinician has planned",
          "APOL1 testing offered after counseling: a result would not change her medicines or blood pressure target now, may inform her risk and any future transplant evaluation, and has implications for relatives; the federal genetic nondiscrimination law does not cover life or long-term care insurance. She chose to defer, and may ask at any time",
          "Kidney education session now on the treatment options should her kidneys fail, and a dietitian session (sodium below 2 g a day, protein about 0.8 g per kg)"
        ],
        "communication": "Discussed with Dr. Ashworth-Banks the same day. The calculations behind each eGFR, the risk estimate and the reasons for each medicine were shown to Mrs. Wells, who asked questions and agreed to start losartan and to the plan for dapagliflozin",
        "follow_up": "Nephrology review in three months with the urine albumin-to-creatinine ratio, then every three to six months while eGFR is below 45 and falling. Transplant evaluation and discussion of dialysis access or conservative care when eGFR approaches 20 or the 2-year kidney failure risk passes 10%, earlier if she wishes. Sooner for potassium above 5.5 mmol/L, a fall in eGFR of more than 30% after starting medicines, or blood in the urine. Dr. Ashworth-Banks continues primary care and monitoring"
      },
      "guideline_ids": [
        "GL-KDIGO-CKD-2024",
        "GL-NKF-ASN-2021",
        "GL-CKDEPI-2021",
        "GL-KDIGO-BP-2021",
        "GL-KDIGO-MBD-2017",
        "GL-AHA-HTN-2025"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She wants to know exactly how sick her kidneys are, how the number was calculated, and why an earlier result was called normal",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She wants to keep working and finish her memoir",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Blood pressure below 130/80 mmHg in the clinic and at home within two months of starting treatment, and lower if tolerated",
        "status": "active",
        "target_date": "2026-03-03",
        "outcome": "132/80 in the clinic and 130/78 at home on losartan 50 mg and dapagliflozin; losartan increased to 100 mg",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Urine albumin-to-creatinine ratio lower by at least 30% at the three-month check on treatment",
        "status": "active",
        "target_date": "2026-03-03",
        "outcome": "240 and 228 mg/g at baseline; repeat due at three months on treatment",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "No NSAIDs or other avoidable kidney harms; every medicine checked against her kidney function",
        "status": "completed",
        "target_date": "2026-03-03",
        "outcome": "Naproxen stopped at intake; acetaminophen used instead; medicines checked at every visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medication safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "An informed decision about APOL1 genetic testing, made by her after counseling",
        "status": "completed",
        "target_date": "2026-01-20",
        "outcome": "Counseled at the consultation; she chose to defer the test and may ask for it at any time",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic shared decision goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "She understands her stage, her risk and the kidney replacement options, and her wishes are recorded, long before any decision is needed",
        "status": "completed",
        "target_date": "2026-02-17",
        "outcome": "Kidney education session completed; wishes recorded at the annual wellness visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic shared decision goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Nephrology consultation for reduced kidney function (race-free eGFR 38) with albuminuria of uncertain cause, a 5-year kidney failure risk above 5% if the disease proves chronic, and APOL1 genetic counseling",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Confirm and stage the kidney disease: race-free eGFR from creatinine with cystatin C, repeat urine albumin-to-creatinine ratio, urinalysis with microscopy, kidney ultrasound, a monoclonal protein screen (serum protein electrophoresis and free light chains), hepatitis B, hepatitis C and HIV tests, and any earlier results she can obtain",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-NKF-ASN-2021",
          "GL-CKDEPI-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Blood pressure: a validated home monitor with readings twice a day for seven days to confirm the diagnosis; sodium below 2 g a day; recheck in two weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-KDIGO-BP-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Stop over-the-counter naproxen and use acetaminophen for knee aching; avoid all NSAIDs; tell every clinician and pharmacist about her kidneys before new medicines or contrast dye",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nephrotoxin plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Anemia and mineral and bone checks: hemoglobin with iron studies, calcium, phosphate, intact PTH and 25-hydroxyvitamin D at baseline",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-MBD-2017",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Baseline ECG, TSH for tiredness, a lipid panel once at diagnosis, A1c to screen for diabetes, and a PHQ-9",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-AHA-HTN-2025",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "On the nephrologist's advice: losartan 50 mg daily with potassium and creatinine in two weeks, then dapagliflozin 10 mg daily with a further check at two to four weeks, then losartan increased to the highest dose tolerated; sick-day rules for both; atorvastatin 20 mg; vitamin D3 1,000 units daily with PTH and vitamin D again at three months; blood pressure goal below 130/80 and a systolic below 120 if tolerated",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-BP-2021",
          "GL-KDIGO-MBD-2017",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-008",
        "display": "APOL1 genetic testing offered after counseling on what a result would and would not change, on privacy, and on what it could mean for relatives; her decision to defer recorded, with the offer left open",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic shared decision at the consultation; no genetic result exists in the record.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-009",
        "display": "Kidney education session on the kidneys and the treatment options if they fail (transplant, home and center dialysis, and conservative kidney management), long before any decision is needed; kidney diet session with the dietitian",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic education plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-010",
        "display": "Vaccines for chronic kidney disease: high-dose influenza, PCV20 and two doses of HepB-CpG (she was not immune), then RSV, recombinant zoster and COVID-19, spaced at her request",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan decided once hepatitis B serology was known.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-011",
        "display": "Dapagliflozin 10 mg daily started now that potassium and creatinine are stable on losartan",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic step decided at the two-week check.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-02-03"
      },
      {
        "id": "INT-012",
        "display": "Losartan increased to 100 mg; potassium and creatinine in two to four weeks; urine albumin-to-creatinine ratio, hemoglobin, PTH and vitamin D at three months on treatment; nephrology review at three months",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-BP-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic step decided at the last visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T09:00:00-05:00"
        },
        "recorded_date": "2026-03-03"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-KDIGO-CKD-2024",
        "title": "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38490803/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-NKF-ASN-2021",
        "title": "A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease",
        "publisher": "National Kidney Foundation and American Society of Nephrology (J Am Soc Nephrol 2021)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34556489/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CKDEPI-2021",
        "title": "New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race",
        "publisher": "New England Journal of Medicine (Inker LA, et al.)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34554658/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-KDIGO-BP-2021",
        "title": "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33637192/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-KDIGO-MBD-2017",
        "title": "Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/28646995/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-AHA-HTN-2025",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults",
        "publisher": "American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40815242/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, anemia and depression monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AWV-CMS",
        "title": "Medicare Wellness Visits (Medicare Learning Network)",
        "publisher": "Centers for Medicare & Medicaid Services",
        "url": "https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BRCA-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-OSTEO-2025",
        "title": "Osteoporosis to Prevent Fractures: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-USPSTF-FALLS-2024",
        "title": "Falls Prevention in Community-Dwelling Older Adults: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions",
        "version_or_year": "2024"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the race-free eGFR values (creatinine 40, creatinine with cystatin C 38) and the race-based value for comparison, the G3b A2 staging, the kidney failure risk estimate, the sequencing of losartan and dapagliflozin with potassium and creatinine checks, the statin for an adult over 50 with eGFR below 60, vitamin D replacement, and the APOL1 counseling."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: the National Park Service, the National Women's History Museum, Women in World History (Encyclopedia.com), the Tennessee Encyclopedia and the University of Chicago Library finding aid. The Library of Congress, the Chicago Defender, Paula Giddings's biography and Crusade for Justice could not be read directly."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health claim is made; mood screening is synthetic and below the threshold for a safety assessment. Her death is stated once, without speculation about its cause beyond kidney disease or uremia as the sources give it."
    }
  }
}
